Eiger BioPharmaceuticals EIGR
$ 1.73
-9.21%
Annual report 2023
added 04-08-2024
Eiger BioPharmaceuticals Total Shareholders Equity 2011-2024 | EIGR
Annual Total Shareholders Equity Eiger BioPharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-14.5 M | 55.3 M | 72.4 M | 95 M | 56.5 M | 66.6 M | 22.5 M | 40.7 M | -5.15 M | 531 K | 105 K | -28.4 M | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
95 M | -28.4 M | 30.1 M |
Quarterly Total Shareholders Equity Eiger BioPharmaceuticals
2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
-1.6 M | 15.3 M | 35.2 M | 55.3 M | 78.3 M | 103 M | 97.3 M | 72.4 M | 89.5 M | 109 M | 126 M | 95 M | 95 M | 95 M | 95 M | 56.5 M | 56.5 M | 56.5 M | 56.5 M | 66.6 M | 66.6 M | 66.6 M | 66.6 M | 22.5 M | 22.5 M | 22.5 M | 22.5 M | 40.7 M | 40.7 M | 40.7 M | 40.7 M | -5.15 M | -5.15 M | -5.15 M | -5.15 M | 531 K | 72.1 M | 72.1 M | 72.1 M | 105 K | -51 M | -51 M | -51 M | 248 K | - | - | - | -71 M | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
126 M | -71 M | 41.7 M |